Mounjaro
Active Ingredient(s): TirzepatideFDA Approved: * May 13, 2022
Pharm Company: * ELI LILLY CO
Category: Diabetes
* May have multiple approval dates, manufacturers, or labelers.
Dosage List
Mounjaro 12.5 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-1460
Labeler:
Eli Lilly and Company